Literature DB >> 1597660

Effect of Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes.

C De Simone1, A Ciardi, A Grassi, S Lambert Gardini, S Tzantzoglou, V Trinchieri, S Moretti, E Jirillo.   

Abstract

In 15 elderly individuals lyophilized Bifidobacterium bifidum (BB) and Lactobacillus acidophilus (LA) (Infloran) were administered in capsules (two capsules 4 times per day) for 28 days, while in 10 elderly controls placebo were given the same posology and for an equal period of time. The effects of this treatment on the immune system both at the periphery or the intestinal level were investigated. Results show that BB and LA significantly reduced the colonic inflammatory infiltration, without altering T, B and Leu7 + cell percentage. At the same time, a significant increase of B cell frequency in the peripheral blood was noted, in comparison to controls. The overall results suggest that the regular administration of BB and LA leads to a modulation of the immunological and inflammatory response in elderly subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597660     DOI: 10.3109/08923979209009228

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  14 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

2.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  West J Med       Date:  1999-09

Review 3.  Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update.

Authors:  Alessandro Di Cerbo; Federica Pezzuto; Lucia Palmieri; Valentina Rottigni; Tommaso Iannitti; Beniamino Palmieri
Journal:  Int Urol Nephrol       Date:  2013-04-13       Impact factor: 2.370

4.  Probiotics: Potent Immunomodulatory Tool Against Allergy.

Authors:  Umesh Kr Shandilya; Sagar Jadhav; Vandana Panwar; V K Kansal
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

Review 5.  Use of probiotics in children with acute diarrhea.

Authors:  Hania Szajewska; Jacek Z Mrukowicz
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

Authors:  P V Kirjavainen; T Arvola; S J Salminen; E Isolauri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

7.  Dysbiosis in ukrainian children with irritable bowel syndrome affected by natural radiation.

Authors:  Mohammad-Reza Sheikh Sajjadieh; Larisa V Kuznetsova; Vadim B Bojenko
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

8.  Bacillus subtilis natto: a non-toxic source of poly-γ-glutamic acid that could be used as a cryoprotectant for probiotic bacteria.

Authors:  Aditya R Bhat; Victor U Irorere; Terry Bartlett; David Hill; Gopal Kedia; Mark R Morris; Dimitris Charalampopoulos; Iza Radecka
Journal:  AMB Express       Date:  2013-07-05       Impact factor: 3.298

9.  Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study.

Authors:  A R Khalighi; M R Khalighi; R Behdani; J Jamali; A Khosravi; Sh Kouhestani; H Radmanesh; S Esmaeelzadeh; N Khalighi
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

10.  Characterization of the Fecal Bacterial Microbiota of Healthy and Diarrheic Dairy Calves.

Authors:  D E Gomez; L G Arroyo; M C Costa; L Viel; J S Weese
Journal:  J Vet Intern Med       Date:  2017-04-07       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.